Danaher Corporation (NYSE:DHR) Shares Acquired by Norris Perne & French LLP MI

Norris Perne & French LLP MI lifted its position in Danaher Corporation (NYSE:DHR - Free Report) by 1.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 132,420 shares of the conglomerate's stock after purchasing an additional 2,064 shares during the quarter. Danaher makes up 2.0% of Norris Perne & French LLP MI's investment portfolio, making the stock its 16th biggest holding. Norris Perne & French LLP MI's holdings in Danaher were worth $27,146,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC purchased a new stake in Danaher in the 4th quarter valued at $27,000. Hurley Capital LLC acquired a new position in Danaher in the fourth quarter valued at $34,000. Rialto Wealth Management LLC purchased a new stake in shares of Danaher in the fourth quarter valued at about $34,000. Dunhill Financial LLC boosted its stake in shares of Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares during the period. Finally, Rakuten Securities Inc. grew its holdings in shares of Danaher by 380.0% during the fourth quarter. Rakuten Securities Inc. now owns 168 shares of the conglomerate's stock worth $39,000 after buying an additional 133 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insiders Place Their Bets

In other news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. This represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

A number of research firms have weighed in on DHR. JPMorgan Chase & Co. decreased their price objective on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Citigroup reaffirmed a "buy" rating on shares of Danaher in a report on Monday, April 7th. Jefferies Financial Group dropped their price objective on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research note on Tuesday, April 22nd. Bank of America cut their price objective on shares of Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Finally, Evercore ISI lowered their target price on shares of Danaher from $240.00 to $230.00 and set an "outperform" rating on the stock in a report on Tuesday, April 22nd. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $248.17.

Danaher Stock Down 0.7%

Shares of DHR stock opened at $194.36 on Thursday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.43. The stock has a market cap of $139.10 billion, a PE ratio of 37.74, a price-to-earnings-growth ratio of 2.75 and a beta of 0.77. The business's fifty day moving average is $193.46 and its 200-day moving average is $210.32. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. Equities analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.66%. Danaher's dividend payout ratio is currently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.